These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21514308)

  • 21. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
    Clerk LH; Vincent MA; Barrett EJ; Lankford MF; Lindner JR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1804-9. PubMed ID: 17911341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
    Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
    Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity.
    Moan A; Høieggen A; Seljeflot I; Risanger T; Arnesen H; Kjeldsen SE
    J Hypertens; 1996 Sep; 14(9):1093-7. PubMed ID: 8986909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M; Li HS; Chen R; Shiuchi T; Wu L; Min LJ; Li JM; Tsuda M; Suzuki J; Tomono Y; Tomochika H; Mogi M; Horiuchi M
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1081-7. PubMed ID: 16990512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
    Hsieh PS; Tai YH; Loh CH; Shih KC; Cheng WT; Chu CH
    Metabolism; 2005 Feb; 54(2):157-64. PubMed ID: 15690308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in angiotensin II release and vascular reactivity in hypertensive men: a pilot study.
    Gasic S; Ratheiser K; Wagner O; Nowotny P; Vierhapper H; Waldhäusl W
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1055-62. PubMed ID: 10604480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism.
    Buchanan TA; Thawani H; Kades W; Modrall JG; Weaver FA; Laurel C; Poppiti R; Xiang A; Hsueh W
    J Clin Invest; 1993 Aug; 92(2):720-6. PubMed ID: 8349811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats.
    Guo Q; Minami N; Mori N; Nagasaka M; Ito O; Kurosawa H; Kanazawa M; Kohzuki M
    Hypertens Res; 2008 Mar; 31(3):525-33. PubMed ID: 18497473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND).
    Parhofer KG; Birkeland KI; DeFronzo R; Del Prato S; Bhaumik A; Ptaszynska A
    Int J Clin Pract; 2010 Jan; 64(2):160-8. PubMed ID: 19929980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade.
    Aksnes TA; Flaa A; Sevre K; Mundal HH; Rostrup M; Kjeldsen SE
    Blood Press; 2008; 17(3):156-63. PubMed ID: 18608197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension.
    Haenni A; Reneland R; Lind L; Lithell H
    J Hypertens; 2001 Jan; 19(1):107-12. PubMed ID: 11204289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction.
    Wassmann S; Hilgers S; Laufs U; Böhm M; Nickenig G
    Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1208-12. PubMed ID: 12117739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study.
    Doehner W; Todorovic J; Kennecke C; Rauchhaus M; Sandek A; Lainscak M; van Linthout S; Tschöpe C; von Haehling S; Anker SD
    Int J Cardiol; 2012 Nov; 161(3):137-42. PubMed ID: 21856022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin.
    Touyz RM; Schiffrin EL
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1214-21. PubMed ID: 8998256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above.
    Yasuda G; Yatsu K; Yamamoto Y; Hirawa N
    Kidney Blood Press Res; 2012; 36(1):131-8. PubMed ID: 23095799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II receptor blockade and insulin sensitivity in overweight and obese adults with elevated blood pressure.
    Marinik EL; Frisard MI; Hulver MW; Davy BM; Rivero JM; Savla JS; Davy KP
    Ther Adv Cardiovasc Dis; 2013 Feb; 7(1):11-20. PubMed ID: 23328189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Arterial Stiffness and Skin Microvascular Function: The SUVIMAX2 Study and The Maastricht Study.
    van Sloten TT; Czernichow S; Houben AJ; Protogerou AD; Henry RM; Muris DM; Schram MT; Sep SJ; Dagnelie PC; van der Kallen CJ; Schaper NC; Blacher J; Hercberg S; Levy BI; Stehouwer CD
    Am J Hypertens; 2015 Jul; 28(7):868-76. PubMed ID: 25523296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.
    Chai W; Fu Z; Aylor KW; Barrett EJ; Liu Z
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E640-8. PubMed ID: 27436611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.